The Supreme Court extends a temporary order maintaining mail access to the abortion pill mifepristone while reviewing a case that could limit its availability nationwide.
Posts tagged as “Danco Laboratorie”
Key takeaways: The Supreme Court has agreed to weigh appeals from the Biden administration and drugmaker Danco defending several FDA decisions that made it easier…
Key takeaways: Danco Laboratories has asked the Supreme Court to review a lower court’s decision limiting access to the abortion pill. The Supreme Court’s decision…
Key takeaways: The Supreme Court has paused lower court rulings that would have imposed restrictions on mifepristone. This ruling keeps the drug accessible while the…
The Supreme Court has granted a temporary extension of access to the abortion pill mifepristone until Friday while they consider a legal challenge to the medication's FDA approval. The lower court ruling had increased the gestational age limit for using the drug and reduced the number of required in-person visits. The Biden administration and drug maker Danco Laboratories have requested the Supreme Court to halt the appeals court ruling. The temporary extension of access to mifepristone will remain in place until Friday at 11:59 p.m.
The Supreme Court is expected to make a decision Wednesday on a request by the federal government to immediately block a lower court ruling that would restrict access to the abortion pill mifepristone. The case originated in Judge Matthew Kacsmaryk’s court in Amarillo, Texas, and the outcome of this decision could have a major impact on access to mifepristone and the ability of women to make decisions about their own reproductive health. The Department of Justice has appealed to the Fifth Circuit Court of Appeals and the Supreme Court has temporarily blocked the appeals court ruling while the justices consider what next steps to take.